What is guaifenesin (DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Guaifenesin DM?

Guaifenesin DM is an over-the-counter combination medication containing guaifenesin (an expectorant) and dextromethorphan (a cough suppressant) used to treat cough and mucus-related symptoms associated with upper respiratory tract infections and colds.

Medication Components

Guaifenesin

  • Mechanism: Acts as an expectorant to loosen mucus in airways and make coughs more productive 1
  • FDA-approved indication: "Help loosen phlegm (mucus) and thin bronchial secretions" 1
  • Dosing: 200-400 mg every 4 hours, up to 6 times daily for immediate-release formulations; extended-release formulations available for 12-hourly dosing 2

Dextromethorphan (DM)

  • Mechanism: Cough suppressant that reduces cough frequency and severity 3
  • Function: Works centrally to suppress the cough reflex

Clinical Evidence and Efficacy

The Evidence is Mixed and Controversial

For Guaifenesin:

  • Some studies show decreased subjective cough measures in upper respiratory infections and bronchiectasis 4
  • However, high-quality recent evidence shows no effect on sputum volume, sputum properties, or objective measures in acute respiratory tract infections 5
  • A 2024 review questions its claimed expectorant effect and notes lack of significant benefits over placebo 6

Important caveat: While laboratory studies suggest guaifenesin may reduce mucin production and improve mucociliary clearance 7, this has not consistently translated to clinical benefit in real-world studies 5

For Dextromethorphan:

  • Multiple studies demonstrate statistically significant reductions in cough frequency and severity compared to placebo 3
  • More consistent evidence base than guaifenesin alone

Clinical Use

Despite limited evidence for guaifenesin's efficacy, the combination remains widely used because:

  • Dextromethorphan provides documented cough suppression
  • Guaifenesin has an excellent safety profile in adults and children 2
  • FDA-approved for over-the-counter use
  • May provide symptomatic relief in some patients even if objective measures don't change

Important Clinical Considerations

Laboratory Interference

Guaifenesin interferes with certain lab tests, specifically producing color interference with 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA) determinations 1. Inform the laboratory if your patient is taking this medication before these tests.

Safety Profile

  • Well-established favorable safety and tolerability in adult and pediatric populations 2
  • Generally well-tolerated with minimal side effects

Formulations

Available as oral solutions, tablets, and extended-release formulations in various strengths 1

Bottom Line for Clinical Practice

Use guaifenesin DM when patients need symptomatic relief from cough with mucus production, understanding that the primary benefit comes from the dextromethorphan component for cough suppression, while guaifenesin's expectorant effects remain questionable despite FDA approval. The combination is safe and may provide subjective symptom relief even if objective measures of mucus clearance are unchanged 5, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.